Clinical decision support (CDS) tools are electronic systems that take information in patients' electronic health records and make suggestions to clinicians about how to care for patients. These tools can, for example, see ...
Jun 9, 2022
0
5
(HealthDay) -- Medicare patients who have advanced non-small cell lung cancer appear to get no survival benefit from adding the drug Avastin to standard chemotherapy, researchers from the Dana-Farber Cancer Institute report.
Apr 17, 2012
0
0
For patients with diabetes subsequently diagnosed and hospitalized with COVID-19, use of a sodium-glucose cotransporter-2 inhibitor (SGLT-2i) before COVID-19 infection is associated with lower COVID-19-related adverse outcomes, ...
Dec 7, 2022
0
9
In an observational study, Mayo Clinic researchers report that the combination of casirivimab and imdevimab—two monoclonal antibody treatments under Food and Drug Administration emergency use authorization—keep high-risk ...
Aug 30, 2021
0
76
About 10 percent of patients with psoriasis have a high risk for advanced liver fibrosis, according to a systematic review and meta-analysis published online Dec. 15 in Frontiers in Medicine.
Jan 4, 2023
0
9
Hospitalized patients with COVID-19 may face an increased risk for kidney injury, a dreaded complication for those suffering from infection with the novel 2019 coronavirus, an observational study led by University of Michigan ...
Sep 22, 2020
0
1
Two "big gun" antibiotics thought to cause kidney failure in ICU patients with a severe bacterial infection, especially when combined with another antibiotic, may be safer for the kidneys than previously reported, following ...
Oct 16, 2023
0
7
A new study by researchers at Intermountain Healthcare in Salt Lake City finds that the most commonly prescribed class of anti-depressants does not help reduce the severity of illness or even death for people who get COVID, ...
Nov 7, 2022
0
3
A new study—the largest of its kind globally—has found children with multiple sclerosis (MS) have better outcomes if treated early and with the same high-efficacy therapies as adults. The findings were published in Lancet ...
Mar 25, 2024
0
52
The Favipiravir Observational Study Group (principal investigator: Dr. Yohei Doi, Fujita Health University) released a preliminary report of the Favipiravir Observational Study in Japan on the Japanese Association for Infectious ...
Jun 2, 2020
0
1
